SURMOUNT-5, the first head-to-head trial (published in NEJM, 2025), found tirzepatide produced about 20.2% average weight loss versus 13.7% for semaglutide over 72 weeks
Neuro Endocrinol Lett 32:13340, PMID: 21552194 Kaddurah-Daouk R, Yuan P, Boyle SH, Matson W, Wang Z, Zeng ZB, Zhu H, Dougherty GG, Yao JK, Chen G, Guitart X, Carlson PJ, Neumeister A, Zarate C, Krishnan RR, Manji HK, Drevets W (2012) Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile
Targeting the gastrointestinal tract to treat type 2 diabetes
if it doesn't most commercial plans as of April 2026 PlexusDx Microdose at $1,548/year is the cheapest published online GLP-1 path we have seen
You can expect smoother or firmer skin and less visible blemishes or spots on your skin
Shaking introduces harsh mechanical energy that can break the delicate bonds holding the peptides protein structure together